Search
Biotechnology
15mins
“Until very recently, I thought I would die with the same genome that I was born with.”
From treating specific diseases to targeting aging itself, Progress Conference 2025 explored the many routes to extending life.
13mins
“Over the last 10 or 15 years, scientists have really started to understand the fundamental underlying biology of the aging process. And they broke this down into 12 hallmarks of aging.”
It's time to write the human genome, argues microbiologist Andrew Hessel.
For many of us, our imperfect vision compels us to wear corrective lenses to see properly. Here's what everyone should know about LASIK.
By inviting players to tackle real scientific problems, games can offer a hand in solving medicine’s toughest challenges.
Dreams of resurrecting lost species didn’t start in Hollywood or Silicon Valley.
Welcome to The Nightcrawler — a weekly newsletter from Eric Markowitz covering tech, innovation, and long-term thinking.
Other plans for the tech: organ banking and deep space travel.
Hawking’s refusal to upgrade his communication system preserved a voice that became iconic, not just for its sound, but for the profound identity it conveyed.
“Neurotech is not just about the brain,” says Synchron CTO Riki Banerjee, explaining how their tech can help with paralysis, brain diseases, and beyond.
For a substantial part of human history, people thought smoking tobacco was perfectly healthy. Native American tribes, who introduced the tobacco plant to Europeans and — by extension, the rest […]
Of the millions of substances people encounter daily, health researchers have focused on only a few hundred. Those in the emerging field of exposomics want to change that.
Hang on to something — or ride the wave — because three big tech trends are about to converge.
"The promise of the Human Genome Project has finally arrived."
How technology could change everything we thought we knew about reproduction.
Benjamin Oakes — CEO of buzz-worthy biotech company Scribe Therapeutics — joins Big Think for a chat about innovation, human endeavor, and more.
As creatures and machines meld together in increasingly advanced forms, ethicists are starting to take note.
There is one obstacle that reliably blocks innovative ideas: how we fund science.
Kurzweil predicts that AI will combine with biotechnology to defeat degenerative diseases this decade. Then things will get really interesting.
Hunger rates are rising. These technologies could turn the tide.
"By 2040, we hope to see a number of new drugs that have been designed with AI reaching patients."
Profluent’s new platform is like ChatGPT for genetic technology.
A study of spinal development took a strange turn and made a surprise discovery.
Vaccines targeting some of our deadliest cancers are showing promise in early trials.
What would it take to create a truly intelligent microbot, one that can operate independently?
The sober reality behind the effectiveness of two new drugs touted as Alzheimer's breakthroughs: lecanemab and donanemab.
Long overlooked, menstrual stem cells could have important medical applications, including diagnosing endometriosis
They call it “Judo T-cell therapy,” and it’s 100 times more potent than regular CAR-T cells.
The brain-computer interface will be tested in a six-year trial in patients with quadriplegia.
